In an interview to CNBC-TV18, YK Hamied, chairman and managing director of Cipla says, the company is launching an anti-malarial drug in India. "Today, being the World Malaria day, we are launching a new combination drug along with our partners who are based in Geneva called DNDI," he asserts.
first published: Apr 25, 2012 02:08 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty snaps 4-week gains, slips below 25,800 | Closing Bell

Live: Is Nifty likely to stay in profit-booking mode? | Opening Bell

Groww CEO Lalit Keshre on ₹62,000 Crore IPO, Sebi regulations, valuation expectation and more

How Income Plus Arbitrage Fund of Fund Can Help You Get Stable, Tax-Efficient Returns
You are already a Moneycontrol Pro user.

